Cargando…

PITX3 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients after radical prostatectomy

BACKGROUND: Molecular biomarkers that might help to distinguish between more aggressive and clinically insignificant prostate cancers (PCa) are still urgently needed. Aberrant DNA methylation as a common molecular alteration in PCa seems to be a promising source for such biomarkers. In this study, P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Holmes, Emily Eva, Goltz, Diane, Sailer, Verena, Jung, Maria, Meller, Sebastian, Uhl, Barbara, Dietrich, Jörn, Röhler, Magda, Ellinger, Jörg, Kristiansen, Glen, Dietrich, Dimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037587/ https://www.ncbi.nlm.nih.gov/pubmed/27708722 http://dx.doi.org/10.1186/s13148-016-0270-x

Ejemplares similares

PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
por: Gevensleben, Heidrun, et al.
Publicado: (2016)

CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
por: Goltz, Diane, et al.
Publicado: (2016)

Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2017)

PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
por: Sailer, Verena, et al.
Publicado: (2016)

Improved PCR Performance Using Template DNA from Formalin-Fixed and Paraffin-Embedded Tissues by Overcoming PCR Inhibition
por: Dietrich, Dimo, et al.
Publicado: (2013)

DNA Methylation of PITX2 and PANCR Is Prognostic for Overall Survival in Patients with Resected Adenocarcinomas of the Biliary Tract
por: Uhl, Barbara, et al.
Publicado: (2016)

Performance Evaluation of Kits for Bisulfite-Conversion of DNA from Tissues, Cell Lines, FFPE Tissues, Aspirates, Lavages, Effusions, Plasma, Serum, and Urine
por: Holmes, Emily Eva, et al.
Publicado: (2014)

Intragenic DNA methylation of PITX1 and the adjacent long non-coding RNA C5orf66-AS1 are prognostic biomarkers in patients with head and neck squamous cell carcinomas
por: Sailer, Verena, et al.
Publicado: (2018)

SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas
por: Semaan, Alexander, et al.
Publicado: (2016)

Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
por: Dietrich, Dimo, et al.
Publicado: (2013)

Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites
por: Jung, Maria, et al.
Publicado: (2016)

PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
por: Röver, Lea Kristin, et al.
Publicado: (2018)

Systematic expression analysis of the mitochondrial complex III subunits identifies UQCRC1 as biomarker in clear cell renal cell carcinoma
por: Ellinger, Jörg, et al.
Publicado: (2016)

PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients
por: Goltz, Diane, et al.
Publicado: (2017)

Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?
por: Zhao, Zhongwei, et al.
Publicado: (2017)

Robot-assisted radical prostatectomy significantly reduced biochemical recurrence compared to retro pubic radical prostatectomy
por: Fujimura, Tetsuya, et al.
Publicado: (2017)

The Metabolic Syndrome and Biochemical Recurrence following Radical Prostatectomy
por: Post, Jennifer M., et al.
Publicado: (2011)

Predictive factors for biochemical recurrence in radical prostatectomy patients
por: Turk, Hakan, et al.
Publicado: (2015)

Prediction of biochemical recurrence after laparoscopic radical prostatectomy
por: Bejrananda, Tanan, et al.
Publicado: (2023)

Systematic Analysis of the Expression of the Mitochondrial ATP Synthase (Complex V) Subunits in Clear Cell Renal Cell Carcinoma
por: Brüggemann, Maria, et al.
Publicado: (2017)

Prognostic Factors for the Development of Biochemical Recurrence after Radical Prostatectomy
por: Kotb, Ahmed F., et al.
Publicado: (2011)

Biochemical recurrence after radical prostatectomy: what does it mean?
por: Tourinho-Barbosa, Rafael, et al.
Publicado: (2018)

Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
por: Falagario, Ugo Giovanni, et al.
Publicado: (2023)

Analysis of Tissue and Serum MicroRNA Expression in Patients with Upper Urinary Tract Urothelial Cancer
por: Kriebel, Stephanie, et al.
Publicado: (2015)

LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study
por: Bergheim, Julia, et al.
Publicado: (2018)

Robot-assisted radical prostatectomy has lower biochemical recurrence than laparoscopic radical prostatectomy: Systematic review and meta-analysis
por: Lee, Seon Heui, et al.
Publicado: (2017)

Impact of capsular incision on biochemical recurrence after radical perineal prostatectomy
por: Kwak, K W, et al.
Publicado: (2009)

The Effect of Tumor-Prostate Ratio on Biochemical Recurrence after Radical Prostatectomy
por: Cho, Sung Yong, et al.
Publicado: (2016)

The Prognostic Factors of Biochemical Recurrence-Free Survival Following Radical Prostatectomy
por: Chalieopanyarwong, Virote, et al.
Publicado: (2017)

MRI Characteristics Accurately Predict Biochemical Recurrence after Radical Prostatectomy
por: Manceau, Cécile, et al.
Publicado: (2020)

Are Diabetic Patients at Increased Risk for Biochemical Recurrence After Radical Prostatectomy?
por: Ben Hadj Alouane, Houssem, et al.
Publicado: (2022)

Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy
por: Chung, Dae Hyuk, et al.
Publicado: (2023)

DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature
por: Sailer, Verena, et al.
Publicado: (2019)

Hypertriglyceridemia Is a Potential Preoperative Predictor for Biochemical Recurrence after Radical Prostatectomy
por: Kang, Minyong, et al.
Publicado: (2015)

Comparison of biochemical recurrence in prostate cancer patients treated with radical prostatectomy or radiotherapy
por: Kim, Dong Soo, et al.
Publicado: (2015)

Association Between Surgical Stress and Biochemical Recurrence After Robotic Radical Prostatectomy
por: Meguro, Satoru, et al.
Publicado: (2021)

Integrating Serum Biomarkers into Prediction Models for Biochemical Recurrence Following Radical Prostatectomy
por: Moghaddam, Shirin, et al.
Publicado: (2021)

Diagnostic yield of multiparametric MRI for local recurrence at biochemical recurrence after radical prostatectomy
por: Kim, Minsu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3tvn5rf0ee43nv85om0ha1fr7h